-+ 0.00%
-+ 0.00%
-+ 0.00%

Hansoh Pharma Reports Promising Phase 1 Results for Risvutatug Rezetecan in Advanced NSCLC

Reuters·12/10/2025 09:53:59

Please log in to view news